Pharmacoeconomics and Health Economics Studies

Pharmacoeconomics Studies

In the framework of our CRO (Clinical Research Organisation) activities, we perform pharmacoeconomic and health economic studies for our customers. These include companies, in the pharmaceutical industry, the manufacturers of medical devices and diagnostic equipment, health care institutions and other companies. As a full-service provider, we manage the planning, realisation, statistical analysis and reporting of pharmacoeconomic and health economic studies.

We draw on our year-long experience in the area of product life cycle assessments, including the management of all pre-marketing and post-marketing activities for the realisation of health economic and pharmacoeconomic studies. Prevention research is also a service provided by Dr. Oestreich + Partner GmbH. The application of interactive software solutions in health economic and pharmacoeconomic studies enables increased time and cost savings. It speeds up the conduct of a project and allows a greater amount of flexibility with respect to protocol changes and any interim analyses planned during the course of a study.

Pharmaoeconomic and Health Economic Studies– A Full Range of Services

For optimisation of the cost-benefit ratio a range of measurement techniques will be necessary depending on the specific needs of the customer. The company, Dr. Oestreich + Partner GmbH provides complete and professional support. For example, in the measurement of the quality of life of patients undergoing defined therapies under specific care conditions.
Thus, by means of example, services for the realisation of market research projects and the formulation of marketing strategies can be provided together with the development of networks and software. Telemedicine systems for patient self-monitoring, projects measuring patient satisfaction and managed-care experiments comprise part of our range of services in the area of health economic and, in particular, pharmacoeconomic studies. For large economic studies we can provide electronic data capture technology including a notepad.

Learn more about our services in the section health economic and pharmacoeconomic studies - Click here!

EMA Pharmacovigilance
Health care studies
Observational studies
EMA Pharmacovigilance
Medical Biometrics
Approval of Medical Devices
Clinical Investigators
Clinical Trials
GCP Legislation
GCP - Good Clinical Practice
GCP Guidelines
GCP Compliance
Clinical Research Organisation
Contract Research Organisation
Pharmacoeconomics, Health
Pharmacoeconomic studies
Patient Monitoring
Monitoring Clinical Trials
Clinical Monitor
Marketing Authorisation
Medicinal Product Approval
Drug safety
Data management plan
Clinical development
Monitoring investigators
Non-interventional studies (NIS)
Patient recruitment
Phase IV studies
Investigator audit
Investigator qualification
Investigator selection

EMA Pharmacovigilance · Health care studies · Observational studies · EMA Pharmacovigilance · Medical Biometrics · Approval of Medical Devices · Pharmacovigilance · Clinical Investigators · Clinical Trials · GCP Legislation · GCP - Good Clinical Practice · ICH GCP E6 · GCP Guidelines · GCP Compliance · BfArM GCP · Clinical Research Organisation · Contract Research Organisation · PSUR · PSURs · Pharmacoeconomics, Health · Pharmacoeconomic studies · Pharmacoeconomics · Patient Monitoring · Monitoring Clinical Trials · Clinical Monitor · Marketing Authorisation · Medicinal Product Approval · Drug safety · Data management plan · Clinical development · Monitoring investigators · Non-interventional studies (NIS) · Patient recruitment · Phase IV studies · Investigator audit · Investigator qualification · Investigator selection